Moreover, we validated FGF14 expression in several cancer cell lines, breast (MCF-7), prostate (DU145, PC3) ovary (SKOV3, OVCAR3), liver (HEP2G), pancreatic (MiaPaCa-2, Capan-1), and colon (Colo320, SW480), revealing a substantial variability (Figure S1K). This evidence concerns the gene FGF14 and cancer.